Efficiency to enable equitable inclusion in relation to new technology

Knowledge@Wharton. Health Economics. Code Blue: combating rising healthcare costs calls for strong medicine. Available from: http://knowledge.wharton.upenn.edu/article.cfm?articleid=836. Accessed in 2007 (Nov 14).

Wassertheil-Smoller S, Hendrix SL, Limacher M, et al Effect of estrogen plus progestin on stroke in postmenopausal women: the Women’s Health Initiative: a randomized trial. JAMA. 2003;289(20):2673-84.

Anderson GL, Judd HL, Kaunitz AM, et al. Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women’s Health Initiative randomized trial. JAMA. 2003;290(13):1739-48.

Chlebowski RT, Hendrix SL, Langer RD, et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women’s Health Initiative Randomized Trial. JAMA. 2003;289(24):3243-53.

Corrêa TD, Namura JJ, Silva CAP, Castro MG, Meneghini A, Ferreira C. Hipertensão arterial sistêmica: atualidades sobre sua epidemiologia, diagnóstico e tratamento. [Systemic hyperten- sion: latest information on its epidemiology, diagnosis and treatment]. Arq Méd ABC. 2006;31(2):91-101.